Menicon Co., Ltd.

7780.T
Medical Instruments & Supplies
2026/08/26 Updated
Market Cap: $890.2M (¥141.8B)
Stock Price: $11.99 (¥1,909)
Exchange Rate: 1 USD = ¥159.24

【Menicon】Proposal for Election of Directors and Stock Option Grants|May 2026

Menicon plans to appoint eight directors and provide stock options to directors of subsidiaries at the shareholders' meeting in June 2026, advancing organizational restructuring aimed at enhancing corporate value and increasing management motivation.

Importance:
Page Updated: May 13, 2026
IR Disclosure Date: May 13, 2026

Key Figures

  • Appointment of 8 directors (names and positions)
  • Total stock options granted to directors and employees of subsidiaries: 17,000 shares and 56,000 shares
  • Exercise periods: from March 31, 2027 to March 30, 2077, and from March 31, 2028 to March 30, 2078

AI要約

Overview of the Proposal for the Shareholders' Meeting

At the Board of Directors meeting scheduled for May 13, 2026, Menicon resolved to submit proposals for the appointment of eight directors and issuance of stock options to directors and employees of subsidiaries, targeting the General Meeting of Shareholders on June 26, 2026. The appointment of new directors is planned due to the expiration of current directors' terms, with Koji Shinoda, Hiromi Takeuchi, and Katsuhiko Masumoto expected to be newly appointed. Stock options will be granted to domestic and non-resident directors and employees of subsidiaries, amounting to approximately 17,000 and 56,000 common shares respectively, with exercise periods from March 31, 2027 to March 30, 2077, and from March 31, 2028 to March 30, 2078.

Future Outlook and Impact on Shareholders

The proposed appointment of directors and stock option grants aim to strengthen the company's management structure and motivate employees and executives, contributing to the enhancement of corporate value. For shareholders, this includes anticipation of long-term growth through leadership renewal and incentive provision, though dilution of shares is also a point to consider. These measures are positioned as part of the continuous growth strategy linked to future management plans.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Menicon Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →